Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Juhong Pills (橘红丸) is a traditional Chinese medicine (TCM) formulation primarily indicated for the treatment of respiratory conditions such as cough, excessive phlegm, and bronchitis. The formulation is based on a complex mixture of herbal ingredients, with *Exocarpium Citri Grandis* (Juhong) serving as a principal component. Its therapeutic actions, according to TCM principles, include clearing lung heat, resolving phlegm, and moistening the lungs to alleviate cough. It is manufactured by several pharmaceutical companies in China, including Jiangsu Tiansheng Pharmaceutical, and is typically available as an over-the-counter or prescription oral medication in pill form. The product is officially recognized and approved for clinical use in China for managing symptoms of phlegm-heat cough.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Juhong Pills.